SEC Filing Summary: Organovo Holdings, Inc. (ONVO)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Organovo Holdings, Inc. on March 6, 2025. The report addresses "Other Events" (Item 8.01) regarding corporate actions taken on the same date. Note: The request metadata referenced "Vivosim Labs, INC.", but the filing text explicitly identifies the registrant as Organovo Holdings, Inc.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses solely on the announcement of share issuance activities.
Material Changes
On March 6, 2025, the company announced the issuance of additional shares. This issuance resulted from two specific activities:
- Exercises of warrants by investors.
- At-the-market (ATM) stock sales.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard disclosure of the share issuance event. The full details of the transaction are referenced in the attached press release (Exhibit 99.1), which is not included in the provided text.
Investor Verification Checklist
- Verify the exact number of shares issued via warrant exercises and ATM sales by reviewing Exhibit 99.1 (Press Release).
- Confirm the total proceeds generated from these transactions.
- Assess the impact of the new share issuance on existing shareholder dilution.
- Review the company's remaining warrant obligations and ATM facility capacity.